3/ ACCESS-ATAC is simple to employ—we add a motif-agnostic Ddd enzyme (DddSs) to the standard Tn5 (ATAC) treatment of bulk or single-cell nuclei and use nextgen sequencing to read out chromatin accessibility. It adds no additional cost or effort to the conventional workflow.

Comments